Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
Merck is bulking up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
Merck is bulking up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028. Grouped from 2 articles across 2 sources.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Merck is bulking up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Some 450,000 people without electricity in Belgorod region, while power cut off for 150,000 consumers in Chernihiv. Grouped from 2 articles across 2 sources.
It is unclear if Nick Adams’ position will be paid. Grouped from 2 articles across 2 sources.
Meta, the owner of Facebook, Instagram and Whatsapp, has been ordered to pay $375m (£280m) in damages after it was found to have knowingly harmed children's mental health. Grouped from 2 articles across 2 sources.
Cabbage farmers in the Philippines are harvesting their crops at a loss as prices plunge and fuel costs soar. Grouped from 5 articles across 4 sources.
Danish Prime Minister Mette Frederiksen's Social Democrats look set to suffer the party's worst election outcome in more than a century. Grouped from 2 articles across 2 sources.
Machado's remarks come as the oil industry remains hesitant to invest in Venezuela after the U.S. ousted former President Nicolas Maduro. Grouped from 2 articles across 2 sources.